Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The legally required guidelines for reporting risks or side-effects caused by blood components]

H Radtke1, K Bachmann, G Pindur

  • 1Institut für Transfusionsmedizin und Immunohämatologie Universitätsklinikum Charité, Medizinische Fakultät, Humboldt-Universität zu Berlin.

Infusionstherapie Und Transfusionsmedizin
|June 1, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous microcirculation in patients with peripheral arterial occlusive disease: Comparison of capillary blood circulation in the nail fold of finger and toe.

Clinical hemorheology and microcirculation·2020
Same author

Evaluation of Laser-Doppler-Fluxmetry for the diagnosis of microcirculatory disorders.

Clinical hemorheology and microcirculation·2018
Same author

Reference range and variability of Laser-Doppler-Fluxmetry.

Clinical hemorheology and microcirculation·2017
Same author

Coagulation and complement system in critically ill patients.

Clinical hemorheology and microcirculation·2015
Same author

Tissue oxygen partial pressure in the tibialis anterior muscle in patients with claudication before, during and after a two-stage treadmill stress test.

Biorheology·2014
Same author

Microcirculation in hypertensive patients.

Biorheology·2014

The qualified person for drug safety (Stufenplanbeauftragter) is crucial for managing side effects from medications, especially in transfusion medicine. Implementing legal requirements enhances the safety of blood components and patient health.

Area of Science:

  • Pharmacovigilance and drug safety regulations.
  • Transfusion medicine and blood product safety.

Context:

  • Legal mandates require central registration and evaluation of drug risks, including side effects.
  • Pharmaceutical companies must appoint a qualified person (Stufenplanbeauftragter) responsible for reporting and managing adverse events since 1988.
  • Institutes for transfusion medicine must adhere to drug safety laws ('Arzneimittelgesetz').

Purpose:

  • To summarize the duties of the Stufenplanbeauftragter within transfusion medicine.
  • To present practical experiences of a university institute regarding drug safety.
  • To highlight the importance of regulatory compliance in ensuring blood component safety.

Summary:

  • Blood components are fully subject to drug safety legislation ('Arzneimittelgesetz').

Related Experiment Videos

  • The Stufenplanbeauftragter plays a vital role in initiating measures for serious side effects, particularly concerning viral infectious diseases.
  • Practical application of these legal requirements in transfusion medicine institutes is essential.

    • Impact:

    • Improved safety and security of blood components through adherence to drug safety regulations.
    • Effective management of serious drug side effects, contributing to patient health protection.
    • Successful integration of pharmacovigilance duties within transfusion medicine practices.